contemporary therapeutic issues in cardiovascular disease · 2018-05-04 · issues in...

52
Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist, Schulich Heart Centre Assistant Professor, Department of Medicine University of Toronto 21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Upload: others

Post on 10-Aug-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Noninvasive Evaluation of Coronary Artery Disease:

Anatomical, Functional, Clinical

May 5, 2018

Mark Hansen MD FRCPC Cardiologist, Schulich Heart Centre Assistant Professor, Department of Medicine University of Toronto

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Page 2: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

No Conflict or Disclosure

Page 3: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

LEARNING OBJECTIVES

To develop a greater understanding of the application of cardiac imaging modalities in the detection and management of coronary artery disease:

stress echocardiography myocardial perfusion imaging coronary CT angiography

Page 4: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Coronary Artery Disease

Page 5: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Libby P NEJM 2013;368:2004-2013

Hansson G NEJM 2005;352:1685-1695

Page 6: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Libby P, Theroux P, Circulation 2005;111:23481-3488

Page 7: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events
Page 8: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

When seeking an answer, begin with the right question

Page 9: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Detection vs. Management?

Anatomy vs. Function?

Diagnosis vs. Prognosis?

Page 10: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case

49 year old male Phys. Ed. teacher Diminished exercise capacity ?aging Positive family history of premature CAD BP 148/88 Glucose 5.4 Cholesterol 6.88, TG 4.92, HDL 1.28 GXT: 12min Bruce, 12.8METs, mild dyspnea, peak BP 210/73, 2mm horizontal ST depressions

Page 11: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case

49 year old male Phys. Ed. teacher Diminished exercise capacity ?aging Positive family history of premature CAD BP 148/88 Glucose 5.4 Cholesterol 6.88, TG 4.92, HDL 1.28 GXT: 12min Bruce, 12.8METs, mild dyspnea, peak BP 210/73, 2mm horizontal ST depressions

What Now?

Page 12: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

What Now?

Reassurance? Medical therapy? Stress echocardiography? Myocardial perfusion imaging? CT coronary angiography? Invasive coronary angiography?

Page 13: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

The Ischemic Cascade

Page 14: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

The Ischemic Cascade

Page 15: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

The Ischemic Cascade

Page 16: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

The Ischemic Cascade

Page 17: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events
Page 18: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Will this information:

change health behaviour? change management?

Is this investigation:

cost effective? worth the risk?

Page 19: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case - cont.

Referred for stress echocardiography

Page 20: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

STRESS IMAGING

StressRest

Exercise

Pharmacological

Page 21: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

STRESS ECHO

StressRest

Exercise

Dobutamine

Page 22: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

STRESS ECHO

DisadvantagesAdvantagesCheap No radiation Specific

Operator-dependent Not very sensitive e.g. circumflex ischemia

Special ConsiderationsExtensive literature on pre-op evaluation (dobutamine) Poor images = poor accuracy Inadequate stress = nondiagnostic test Challenging when baseline wall motion abnormality

Page 23: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

STRESS ECHO

Ideal LabIdeal PatientRule-in scenario Interpretable ECG Good image quality Capable of reaching max HR Normal baseline LV function (Serial follow-up)

Direct MD supervision Excellent equipment Excellent sonographer

Page 24: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case - cont.

Stress echocardiography: 12min Bruce, 12.8METs, mild dyspnea, 2mm horizontal ST depressions, normal left ventricular systolic function at rest and stress

What Now?

Page 25: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case - cont.

Referred for myocardial perfusion imaging

Page 26: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

MYOCARDIAL PERFUSION IMAGING

StressRest

ExercisePersantineAdenosine

Page 27: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

MYOCARDIAL PERFUSION IMAGING

DisadvantagesAdvantagesSensitive Quantitative Less operator dependent

Expensive Radiation Less specific (Breast, diaphragm attenuation)

Special ConsiderationsVery extensive literature on prognosis Applicable to known CAD LBBB (pharmacological) Inadequate stress = nondiagnostic test

Page 28: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Ideal LabIdeal PatientRule-out scenario Intermediate body habitus (Not serial follow-up)

Excellent equipment Excellent analysis Case correlation

MYOCARDIAL PERFUSION IMAGING

Page 29: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Einstein A et al. Circulation 2007;116:1290-1305

Page 30: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case - cont.

Exercise myocardial perfusion scan: 12min Bruce, 12.8METs, mild dyspnea, 2mm horizontal ST depressions, normal myocardial scintigraphy, left ventricular volumes, and scintigraphy at rest and stress

What Now?

Page 31: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Boiten H et al. J Nuc Card 2016

Page 32: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case - cont.

Referred for CT coronary angiography

Page 33: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

CT CORONARY ANGIOGRAPHY

Page 34: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

CT CORONARY ANGIOGRAPHY

DisadvantagesAdvantagesExcellent anatomical information Sensitive & specific Quantitative Less operator dependent

Relatively expensive Radiation Contrast Does not provide functional information

Heart rate-dependent Beta-blocker, NTG pre-treatment

Special Considerations

Page 35: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Ideal LabIdeal PatientBradycardia Rule-out scenario Not previous PCI Not extensive Ca++ (Not serial follow-up)

Excellent equipment Excellent analysis Case correlation

CT CORONARY ANGIOGRAPHY

Page 36: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

RANDOMIZED TRIALS IN CARDIOVASCULAR IMAGING

CHALLENGES: ?Study population Core lab vs. community / real life? Indirect association between imaging strategy and outcomes. ?What endpoint

Accuracy? Clinical outcomes? Patient-centred outcomes? Cost-effectiveness?

Page 37: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

NEJM 2015;372(14)

Page 38: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

NEJM 2015;372(14)

PROMISE STUDY

Page 39: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Lancet 2015;385:9985:2383-2391

Page 40: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

J Am Coll Cardiol Img 2011;4:740 –51

Page 41: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 4 , N O . 7 , 2 0 1 1

Page 42: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 4 , N O . 7 , 2 0 1 1

Page 43: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case - cont.

Agatston (Coronary Artery Calcium) score: 0 “No significant coronary arterial calcification in all three vessels. Minimal noncalcified plaque at the proximal D1 causing less than 30% narrowing of the lumen”

Page 44: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Case - cont.

Agatston (Coronary Artery Calcium) score: 0 “No significant coronary arterial calcification in all three vessels. Minimal noncalcified plaque at the proximal D1 causing less than 30% narrowing of the lumen”

What Now?

Page 45: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

What Now?

Reassurance? Medical therapy? Repeat stress testing? Invasive coronary angiography?

Page 46: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

What Now?

Reassurance? Medical therapy? Repeat stress testing? Invasive coronary angiography?

Advised to take ASA, statin, ACE-inhibitor… patient declined

Page 47: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

6 weeks later…

Page 48: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events
Page 49: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events
Page 50: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

Conclusions

GXT, Stress Echo, Myocardial Perfusion Imaging and CT coronary angiography are all reasonable initial diagnostic strategies in patients with suspected coronary artery disease. Choice should be informed by patient factors and local resources. Coronary risk can be estimated, but events are difficult to predict. Integration of all clinical data is necessary in formulating a treatment plan.

Page 51: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events

SUMMARY

Page 52: Contemporary Therapeutic Issues in Cardiovascular Disease · 2018-05-04 · Issues in Cardiovascular Disease. No Conflict or Disclosure. ... Coronary risk can be estimated, but events